Your radiologists read 12,000 studies per year. Each study contains millions of pixels. Each pixel can contain a signal — a 3mm nodule in a lung field, a subtle density change in breast tissue, a hairline fracture obscured by overlapping bone, a 2mm aneurysm in a cerebral vessel. The human eye is extraordinary. It is also exhausted, overworked, and statistically certain to miss findings at a rate of 3-5% even under ideal conditions. Spectra is a multi-modality diagnostic imaging intelligence platform that reads alongside your radiologists — detecting findings across CT, MRI, X-ray, ultrasound, mammography, and PET with the consistency of a machine and the clinical reasoning of a trained observer.
Radiologists are the most cognitively burdened physicians in medicine. They process 3-5 billion medical images per year globally, reading one study every 3-4 minutes, making hundreds of diagnostic decisions per shift, and carrying the knowledge that a single missed finding can mean a delayed cancer diagnosis, a ruptured aneurysm, or a stroke patient who misses the treatment window. The error rate is 3-5% — not because radiologists are careless, but because the human visual system has fundamental limits. A radiologist reading 80 CT studies per day, each with 300+ slices, is making diagnostic judgments on 24,000 images. The 3mm nodule in slice 247 of study 63 at 4:30 PM is statistically likely to be missed — not by a bad radiologist, but by a great radiologist who is human.
Spectra does not replace the radiologist. It reads every study first, at the moment of acquisition, and presents the radiologist with an AI-prioritized worklist: critical findings at the top (large vessel occlusions, tension pneumothorax, aortic dissection), flagged abnormalities in the middle (lung nodules, calcification clusters, aneurysms), and normal studies at the bottom. Every finding is annotated with location, measurement, confidence score, and clinical significance. The radiologist reads with the AI's observations visible — a second pair of eyes that never fatigues, never rushes, and processes every pixel of every slice with the same attention at 4:30 PM as at 8:00 AM.
Spectra operates across the full diagnostic imaging spectrum — not as six separate algorithms, but as a unified intelligence that understands the relationships between modalities and the clinical context of every study.
From critical finding detection through longitudinal comparison — every engine designed to reduce diagnostic error, accelerate time-critical workflows, and reclaim the cognitive capacity that radiologist burnout is consuming.
In stroke, every minute of delayed treatment destroys 1.9 million neurons. In pulmonary embolism, a large saddle embolus can cause cardiac arrest within minutes. In tension pneumothorax, decompression must happen before the formal read is complete. These are the findings where AI's speed advantage over human workflow is not a convenience — it is a clinical imperative. Spectra's critical finding engine analyzes every CT, MRI, and X-ray at the moment the images arrive on the PACS server — before the study enters the radiologist's reading queue. The algorithm has been trained on millions of images containing critical findings and processes a full CT study (300+ slices) in under 90 seconds. When a critical finding is detected, the system generates an alert within 4 minutes of image acquisition: the stroke team is notified of a large vessel occlusion, the ED physician is alerted to a pneumothorax, the vascular surgeon is paged for an aortic dissection. The radiologist receives the study pre-annotated with the finding location, measurement, and confidence score — confirming or refining the AI's detection rather than discovering it cold.
The fundamental challenge of diagnostic imaging is finding small, subtle abnormalities in vast amounts of visual data. A chest CT contains 300+ slices, each with millions of pixels. A 3mm pulmonary nodule occupies approximately 0.001% of the total image data. The radiologist must find it while simultaneously evaluating the mediastinum, the pleural spaces, the vasculature, the bones, and the soft tissues. Spectra's lesion detection engine examines every pixel of every slice with consistent attention — identifying nodules, masses, and lesions across all organ systems and all imaging modalities. Each detected lesion is characterized by size (measured in three dimensions), morphology (solid, ground-glass, cystic, calcified, enhancing), location (anatomical segment and relationship to adjacent structures), and clinical significance (benign-appearing, indeterminate, suspicious). The radiologist receives an annotated study with each finding marked, measured, and characterized — reducing the cognitive burden of detection and allowing focus on the higher-order task of clinical interpretation.
Radiology worklists are traditionally ordered by acquisition time — first in, first out. This means that a normal chest X-ray acquired at 2:00 PM is read before a CT head with a large vessel occlusion acquired at 2:15 PM. The 15-minute delay is clinically insignificant for the chest X-ray and potentially catastrophic for the stroke patient. Spectra's intelligent worklist analyzes every study at acquisition, classifies it by clinical urgency, and reorders the radiologist's reading queue in real time. Critical findings (stroke, PE, dissection, hemorrhage, pneumothorax) are escalated to the top of the list with a red priority indicator and an automated alert to the clinical team. Flagged studies (new nodules, suspicious masses, unexpected findings) receive an orange priority. Routine and normal-appearing studies receive standard priority. The radiologist reads the most urgent studies first — not because they happened to arrive first, but because they need to be read first.
A lung nodule is measured at 7mm by the morning radiologist and 9mm by the evening radiologist reading the same study. The 2mm difference is within normal inter-reader variability — but it changes the clinical pathway: a 7mm nodule gets a 12-month follow-up CT, while a 9mm nodule gets a 3-month follow-up or biopsy. Treatment decisions depend on measurements, and measurements depend on who is measuring. Spectra's automated measurement engine provides consistent, reproducible measurements across all studies: lesion size in three dimensions (long axis, short axis, and perpendicular), organ volumes (liver, spleen, kidneys, heart chambers), vessel diameters (aorta, coronary arteries, cerebral vasculature), bone measurements (vertebral body height for compression fracture assessment), and treatment response metrics (RECIST criteria for tumor response). The AI measures the same way every time — reducing inter-reader variability from 18% to 2% and ensuring that the 7mm nodule is always reported as 7mm, regardless of who reads the study.
The clinical significance of an imaging finding often depends on whether it has changed since the prior study. A stable 6mm lung nodule present for 2 years is almost certainly benign. A 6mm nodule that was 4mm one year ago is growing and may be malignant. Determining interval change requires comparing the current study with the prior study — slice by slice, measurement by measurement — a task that is tedious, time-consuming, and prone to error when done manually. Spectra's comparison engine automatically retrieves all prior studies for the same anatomic region, registers the images to account for differences in patient positioning and breathing, identifies all previously detected lesions and measures them at the current time point, calculates interval change with quantitative precision (a nodule that was 5.2mm is now 6.1mm — a 17% increase over 12 months), and flags new findings that were not present on prior imaging. The radiologist sees the comparison presented as a structured change report — not as two studies to be mentally compared side by side.
Incidental findings are the silent epidemic of diagnostic imaging. A CT scan performed for abdominal pain reveals a 1.2cm thyroid nodule as an incidental finding. The radiologist notes it in the report with a recommendation for thyroid ultrasound follow-up. But the ordering physician is focused on the abdominal pain, the recommendation is buried in paragraph 4 of a 12-paragraph report, and the thyroid ultrasound never happens. Six months later, the patient presents with a thyroid mass that has grown to 3cm and is now malignant. This scenario occurs every day in every health system. Spectra's incidental finding engine tracks every incidental finding from the moment of detection: the finding is catalogued with its ACR white paper follow-up recommendation, the ordering physician receives a structured alert highlighting the incidental finding and its recommended follow-up, the patient's record is flagged with the pending follow-up, and if the recommended study has not been scheduled within the guideline timeframe, an escalation alert is generated. Incidental finding follow-up compliance improves from 46% (the national average) to 94%.
Radiology reporting is the final step in the diagnostic chain — and it is often the bottleneck. A radiologist who reads a study in 3 minutes may spend another 3 minutes dictating the report. For complex studies, the report may include dozens of measurements, multiple comparison references, and scoring system classifications that must be correctly applied. Spectra's reporting engine pre-populates the radiology report with AI-generated findings: each detected abnormality is described with standardized terminology, measured in three dimensions, compared with prior measurements, and classified according to the appropriate scoring system (BI-RADS for breast, LI-RADS for liver, PI-RADS for prostate, TI-RADS for thyroid, Lung-RADS for pulmonary nodules). The radiologist reviews the pre-populated report, confirms or modifies the findings, and signs — reducing total reporting time by 35% while improving report completeness and standardization.
Health systems running population screening programs — breast cancer screening, lung cancer screening, colon cancer screening — face a fundamental tension between volume and quality. More screening saves more lives, but higher volumes increase radiologist workload, cognitive fatigue, and error rates. Spectra's population analytics engine monitors the entire screening enterprise: detection rates by radiologist (identifying readers whose detection rates fall below the group median), false-positive rates (identifying readers whose callback rates are unnecessarily high), reading speed patterns (identifying the time of day and day of week when error rates increase), throughput capacity (modeling the maximum screening volume that can be sustained without quality degradation), and outcome tracking (correlating screening results with downstream pathology to calculate true positive and false negative rates). These analytics enable continuous quality improvement: individual radiologists receive confidential performance dashboards, program directors see aggregate quality metrics, and workforce planning is informed by data-driven capacity modeling.
A Level I trauma center processing 180,000 imaging studies per year deployed Spectra across all CT and MRI scanners. Critical finding detection reduced the average time from image acquisition to clinical alert from 42 minutes (waiting for radiologist read in queue order) to 4 minutes (AI detection with automated notification). In the first 12 months, the system identified 14 large vessel occlusion strokes where the AI alert reached the stroke team before the radiologist had opened the study — enabling thrombectomy within the treatment window for patients who would have experienced treatment delays under the prior workflow. The stroke neurologist reported that the 38-minute time savings per LVO case translated directly to brain tissue preserved: at 1.9 million neurons lost per minute of delayed treatment, the earlier alerts preserved an estimated 100+ million neurons across the 14 patients.
A regional breast screening program processing 62,000 mammograms per year deployed Spectra's mammography engine as a concurrent read — every mammogram read independently by the AI and by a radiologist, with discordant cases reviewed by a second radiologist. Cancer detection rate improved 21% compared to single-radiologist reading — identifying cancers that were visible in retrospect but had been missed on the initial read, predominantly in dense breast tissue where overlapping structures obscure small masses. Simultaneously, the false-positive callback rate decreased 14% because the AI's characterization reduced unnecessary recalls for benign-appearing calcifications and cysts. The combined effect — more cancers found, fewer false alarms — represents the ideal screening outcome. Throughput increased 28% because the AI pre-read allowed radiologists to review AI-annotated studies faster than unassisted reads.
An academic medical center had identified incidental finding follow-up as a patient safety gap: internal audit showed that only 46% of incidental findings with recommended follow-up imaging actually received that follow-up within the guideline timeframe. Spectra's incidental finding engine was deployed to track every incidental finding from detection through resolution. Follow-up compliance improved to 94% within 6 months. In the first year, the tracking system identified 3 cancers — a thyroid carcinoma, a renal cell carcinoma, and an early-stage ovarian cancer — that were initially detected as incidental findings on imaging studies performed for other reasons. Under the prior 46% follow-up rate, these cancers had a greater-than-50% probability of not receiving timely follow-up — meaning they would have been diagnosed months or years later at a more advanced stage.
I read 80 CT studies a day. Each one has 300 to 1,200 slices. By 3 PM, I have looked at 40,000 images. My eyes are tired. My attention is fraying. And the next study in my queue is a stroke alert — a study where every minute matters, where the difference between a good outcome and a devastating one is measured in the time it takes me to open the study and see the occlusion. Spectra saw it before I did. Four minutes after acquisition, the stroke team was notified. I confirmed the finding when I opened the study six minutes later. But those six minutes were the difference. The interventionalist told me the clot was retrieved within the treatment window because of those six minutes. I am a good radiologist. I have been reading for 18 years. But I cannot read faster than an algorithm that processes every pixel the moment the images arrive. And in stroke, the algorithm's speed saves brain.
We screen 62,000 women per year. Every mammogram I read, I know the statistics: I will miss approximately 1 in 8 cancers that are present in the images I review. Not because I am careless. Because some cancers are invisible in dense tissue, because overlapping structures create noise, and because my visual system has limits. Spectra found 21% more cancers than I did alone. Twenty-one percent. For a screening program our size, that translates to approximately 28 additional cancers detected per year — 28 women who received their diagnosis at an earlier stage, with a better prognosis, because a machine saw what I could not see. I don't feel replaced. I feel supported. The AI catches what I miss. I catch what the AI misreads. Together, we are better than either of us alone.
We audited our incidental finding follow-up rate. Forty-six percent. Fewer than half of the incidental findings we reported — thyroid nodules, adrenal masses, renal cysts with complex features — received the follow-up imaging we recommended. The other 54% were lost. Lost in the gap between a recommendation buried in paragraph 4 of a radiology report and an ordering physician focused on the clinical question that prompted the study. Spectra tracks every incidental finding from detection through follow-up. Our compliance went from 46% to 94%. And in the first year, we found three cancers — three actual cancers — in patients whose incidental findings would have been in the 54% that gets lost. Those three patients have cancer that was found early because a system tracked what humans forgot to follow.
Request a clinical demonstration of Spectra — including live AI pre-read on CT, MRI, and mammography studies with side-by-side comparison to unassisted interpretation.